Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GRAIL, Inc. - Common Stock (NQ: GRAL )

55.02 +2.44 (+4.64%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about GRAIL, Inc. - Common Stock

Grail Shares Spiked Wednesday: What's Going On?
Grail shares are trading higher Wednesday after the company announced a new collaboration with Quest Diagnostics aimed at improving provider access to its Galleri multi-cancer early detection test. 
Via Benzinga
Jim Cramer Recommends Buying 'Fabulous' BlackRock, Calls Coterra Energy The 'Cheapest' Natural Gas Company
Cramer comments on Danaher, Coterra, BlackRock and Digital Realty. As for Grail, "Just great science, but it is parabolic," he adds. 
Via Benzinga
Topics Energy
Exposures Fossil Fuels
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
What's Going On With Illumina Stock On Monday?
Illumina exits Nasdaq-100, reports Q3 EPS of $1.14 beating estimates, faces macroeconomic challenges, and lowers 2024 revenue guidance. 
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
GRAL Stock Earnings: GRAIL Reported Results for Q2 2024
GRAIL just reported results for the second quarter of 2024. 
Via InvestorPlace
GRAIL: Biotech Stock Targeting $100B Cancer Market
GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market. 
Via MarketBeat
Topics Death
Exposures Death
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine
Illumina welcomes the European Court of Justice ruling that the European Commission lacked jurisdiction over its acquisition of GRAIL, confirming Illumina's stance. The ruling nullifies a €432 million... 
Via Benzinga
3 Top Cancer Treatment Stocks to Buy Now
These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term. 
Via InvestorPlace
Dow Rallies To All-Time Highs, Small Caps Outperform Tech, Gold Hits Records On Heightened September Rate Cut Bets: What's Driving Markets Tuesday?
Wall Street continues to experience a series of memorable days, with the bulls riding the rally with increasing confidence, certain that the Federal Reserve will begin cutting interest rates in... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
3 Spinoff Stocks You Should Buy Now: July 2024
Spinoff stocks often take time to gain their footing in the market giving investors an opportunity to get in early. 
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Investors should consider buying into one of the future avenues of medicine by investing in these three BNA biotech stocks. 
Via InvestorPlace
Dear AMZN Stock Fans, Mark Your Calendars for July 16
Amazon stock is worth watching for AMZN investors on July 16 as that's when the e-commerce company will start its Prime Day sales. 
Via InvestorPlace
Tesla Cybertruck Recalls: What to Know as Tesla Recalls Thousands of EVs
The Tesla Cybertruck recalls continue with the electric vehicle (EV) company seeking to repair issues with thousands of the trucks. 
Via InvestorPlace
Topics Electric Vehicles Product Recall
Exposures Electric Vehicles Legal Product Safety
Why Is SolarEdge (SEDG) Stock Down 17% Today?
SolarEdge stock is falling on Tuesday as SEDG investors react to one of the company's customers goin bankruptcy without paying back debts. 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
GRAL Stock Alert: 7 Things to Know as Grail Starts Trading Today
New biotech stock Grail begins trading on the Nasdaq today. Here's what investors need to know about GRAL stock. 
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.